MAPKAP-K2 Assay (Screening) Kit, GFP Detection
from
GE Healthcare, formerly Amersham Biosciences
Description
MAPKAP-k2
Validated stable cell line: start screening immediately without having to spend months establishing a cell line in-house.
Expression vector: offers the flexibility to work with transients and alternative host cell lines.
Complete right to use: no additional license negotiations are required prior to using the assay.
Direct observation of MAPKAP-k2 movement and location: permits pathway dissection in correct physiological context, identifies inhibitors of p38 MAPK signaling pathway .
Cellular assay: identifies potentially toxic compounds without the need for additional reagents.
Utilizes Aequorea victorea GFP: the established benchmark fluorescent protein technology.
MAPKAPK2
(MAPKAP kinase 2)